128 related articles for article (PubMed ID: 1703577)
41. B-cell antigen marker expression in nasopharyngeal carcinoma.
Zhong XY; Senba M; Gu JN; Itakura H
Zentralbl Pathol; 1993 Nov; 139(4-5):281-6. PubMed ID: 7510513
[TBL] [Abstract][Full Text] [Related]
42. Heterogeneity of epithelial marker expression in routinely processed, poorly differentiated carcinomas.
Kamel OW; Rouse RV; Warnke RA
Arch Pathol Lab Med; 1991 Jun; 115(6):566-70. PubMed ID: 1710100
[TBL] [Abstract][Full Text] [Related]
43. Vulvar and breast Paget's disease with synchronous underlying cancer: a unique association.
Spiliopoulos D; Spiliopoulos M; Dandolu V; Mastrogiannis D
Arch Gynecol Obstet; 2009 Aug; 280(2):313-5. PubMed ID: 19112575
[TBL] [Abstract][Full Text] [Related]
44. [Gallbladder cancer: immunohistochemical expression of CA-19-9, epithelial membrane antigen, dupan-2 and carcinoembryonic antigen].
Roa I; Araya JC; Shiraisch T; Yatani R; Wistuba I; Villaseca M; de Aretxabala X
Rev Med Chil; 1992 Nov; 120(11):1218-26. PubMed ID: 1340939
[TBL] [Abstract][Full Text] [Related]
45. Paget's disease and melanoma of the vulva. Use of a panel of monoclonal antibodies to identify cell type and to microscopically define adequacy of surgical margins.
Bacchi CE; Goldfogel GA; Greer BE; Gown AM
Gynecol Oncol; 1992 Aug; 46(2):216-21. PubMed ID: 1379962
[TBL] [Abstract][Full Text] [Related]
46. Paget's disease of the vulva: report of a case.
Webb AN
Trans Pac Coast Obstet Gynecol Soc; 1977; 44():54-6. PubMed ID: 199967
[No Abstract] [Full Text] [Related]
47. [The prognosis and immunohistochemical evaluation of five perianal Paget's disease cases].
Amano K; Kumamoto K; Ohsawa T; Okada N; Ishibashi K; Inokuma S; Nakada H; Yokoyama M; Haga N; Ishida H
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2653-5. PubMed ID: 21224669
[TBL] [Abstract][Full Text] [Related]
48. Mammary and extramammary Paget's disease. An immunocytochemical and ultrastructural study.
Ordóñez NG; Awalt H; Mackay B
Cancer; 1987 Mar; 59(6):1173-83. PubMed ID: 2434206
[TBL] [Abstract][Full Text] [Related]
49. Application of immunocytochemistry to the cytologic study of peritoneal fluids in patients with ovarian cancer.
Shinozuka T; Ebisawa K; Miyamoto T; Murakami M; Fujii A; Osamura Y
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Oct; 43(10):1355-62. PubMed ID: 1955789
[TBL] [Abstract][Full Text] [Related]
50. Paget's disease of the vulva: clinicopathologic study of type 1 cases treated at a single institution.
Niikura H; Yoshida H; Ito K; Takano T; Watanabe H; Aiba S; Yaegashi N
Int J Gynecol Cancer; 2006; 16(3):1212-5. PubMed ID: 16803508
[TBL] [Abstract][Full Text] [Related]
51. Mucin-negative biopsy in extra-mammary Paget's disease. A diagnostic problem.
Alguacil-Garcia A; O'Connor R
Histopathology; 1989 Oct; 15(4):429-31. PubMed ID: 2478441
[TBL] [Abstract][Full Text] [Related]
52. Primary extramammary Paget's disease of the vulva: the clinicopathological features and treatment outcomes in a series of 43 patients.
Cai Y; Sheng W; Xiang L; Wu X; Yang H
Gynecol Oncol; 2013 May; 129(2):412-6. PubMed ID: 23454498
[TBL] [Abstract][Full Text] [Related]
53. Paget's disease of the vulva detected in vulvar and vaginal brushing smears: a case report.
Klapsinou E; Terzakis E; Arnogiannaki N; Daskalopoulou D
Acta Cytol; 2010; 54(5 Suppl):898-902. PubMed ID: 21053565
[TBL] [Abstract][Full Text] [Related]
54. [Micro-invasive vulvar Paget's disease and lymph node metastasis: a same disease?].
Quintyn-Ranty ML; Escourrou G; Paute A; Viale J; Guilbeau C; Delisle MB
Ann Pathol; 2011 Oct; 31(5):341-4. PubMed ID: 21982239
[TBL] [Abstract][Full Text] [Related]
55. Behavior of epithelial differentiation antigens (carcinoembryonic antigen, epithelial membrane antigen, keratin and cytokeratin) in transitional cell carcinomas of the bladder.
Sánchez-Fernández de Sevilla MC; Morell-Quadreny L; Gil-Salom M; Pérez-Bacete M; Fenollosa-Entrena B; Llombart-Bosch A
Urol Int; 1992; 48(1):14-9. PubMed ID: 1376008
[TBL] [Abstract][Full Text] [Related]
56. Paget disease of the vulva: a histologic study of 56 cases correlating pathologic features and disease course.
Shaco-Levy R; Bean SM; Vollmer RT; Papalas JA; Bentley RC; Selim MA; Robboy SJ
Int J Gynecol Pathol; 2010 Jan; 29(1):69-78. PubMed ID: 19952933
[TBL] [Abstract][Full Text] [Related]
57. Conservative management of extramammary Paget's disease of the vulva.
Bergen S; DiSaia PJ; Liao SY; Berman ML
Gynecol Oncol; 1989 May; 33(2):151-6. PubMed ID: 2539315
[TBL] [Abstract][Full Text] [Related]
58. The immunoperoxidase localization of tumour markers in ovarian cancer: the value of CEA, EMA, cytokeratin and DD9.
Hammond RH; Bates TD; Clarke DG; Grant AG; Haines AM; Eustace DL; Heyderman E
Br J Obstet Gynaecol; 1991 Jan; 98(1):73-83. PubMed ID: 1705435
[TBL] [Abstract][Full Text] [Related]
59. A comparative study of cytokeratin expression in Paget cells located at various sites.
Watanabe S; Ohnishi T; Takahashi H; Ishibashi Y
Cancer; 1993 Dec; 72(11):3323-30. PubMed ID: 7694788
[TBL] [Abstract][Full Text] [Related]
60. Simultaneous vulvar intraepithelial neoplasia and Paget's disease: report of two cases.
Orlandi A; Piccione E; Francesconi A; Spagnoli LG
Int J Gynecol Cancer; 2001; 11(3):224-8. PubMed ID: 11437929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
